Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

BACKGROUND: Using phase 3 trial data for sunitinib versus interferon (IFN)-α in treatment-naive patients with metastatic renal cell carcinoma, retrospective analyses characterized sunitinib-associated fatigue and its impact on patient-reported health-related quality of life (HRQoL). METHODS: Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Cella, David, Davis, Mellar P, Négrier, Sylvie, Figlin, Robert A, Michaelson, M Dror, Bushmakin, Andrew G, Cappelleri, Joseph C, Sandin, Rickard, Korytowsky, Beata, Charbonneau, Claudie, Matczak, Ewa, Motzer, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231253/
https://www.ncbi.nlm.nih.gov/pubmed/24634003
http://dx.doi.org/10.1002/cncr.28660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231253/
https://www.ncbi.nlm.nih.gov/pubmed/24634003
http://dx.doi.org/10.1002/cncr.28660

Ejemplares similares